Table 3.
Multiple linear regression models depicting predictors of spinal immobility at a mean of 5.9 years later among 54 patients with ankylosing spondylitis
Modela | 1 | 2 | 3 | 4 | 5 | |||||
---|---|---|---|---|---|---|---|---|---|---|
Variable | Coef. (95% CI) |
p | Coef. (95% CI) |
p | Coef. (95% CI) |
p | Coef. (95% CI) |
p | Coef. (95% CI) |
p |
Sex | − 0.23 (− 1.55 to 1.09) | 0.731 | − 0.02 (− 1.29 to 1.25) | 0.972 | ||||||
Disease duration at study end | 0.07 (0.02 to 0.12) | 0.011 | 0.07 (0.02 to 0.12) | 0.005 | 0.07 (0.02 to 0.12) | 0.004 | 0.08 (0.03 to 0.13) | 0.002 | 0.08 (0.03 to 0.13) | 0.004 |
hsCRP | 0.39 (0.15 to 0.64) | 0.002 | 0.36 (0.12 to 0.60) | 0.004 | 0.36 (0.13 to 0.59) | 0.003 | 0.37 (0.14 to 0.60) | 0.002 | 0.35 (0.12 to 0.58) | 0.004 |
Exercise in leisure time | − 0.72 (− 1.31 to − 0.12) | 0.019 | − 0.72 (− 1.30 to − 0.14) | 0.017 | − 0.74 (− 1.33 to − 0.16) | 0.014 | − 0.72 (− 1.31 to − 0.13) | 0.018 | ||
NSAID | 0.59 (− 0.48 to 1.66) | 0.273 | 0.73 (− 0.40 to 1.86) | 0.200 | ||||||
BASDAI | − 0.13 (− 0.45 to 0.19) | 0.413 | ||||||||
Adjusted R2 | 0.16 | 0.23 | 0.25 | 0.25 | 0.25 |
Bold font to indicate statistically significant result at p<0.05
hsCRP, high-sensitivity C-reactive protein; NSAID, regular consumption of non-steroid anti-inflammatory drug; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index
aRegression constant not shown